Nu Skin Enterprises, Inc.
NUSNYSEConsumer Defensive● Active
$5.28
$-0.09(-1.68%)
Market Cap$256346867
P/E Ratio—
52W High$14.62
52W Low$5.25
Nu Skin Enterprises, Inc. (NUS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NUS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B |
| Cost of Revenue | $0.45B | $0.55B | $0.61B | $0.63B | $0.68B |
| Gross Profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B |
| Gross Margin %(computed) | 69.45% | 68.23% | 68.93% | 71.65% | 74.95% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.01B | $0.02B | $0.00B | $0.03B |
| G&A Expenses | $0.43B | $0.48B | $0.55B | $0.56B | $0.67B |
| Total Operating Expenses | $0.94B | $1.33B | $1.31B | $1.48B | $1.79B |
| Operating Income | $0.09B | ($0.15B) | $0.05B | $0.11B | $0.23B |
| Operating Margin %(computed) | 6.12% | -8.75% | 2.45% | 4.98% | 8.68% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Interest Expense | $0.01B | $0.03B | $0.03B | $0.02B | $0.01B |
| Income Before Tax | $0.20B | ($0.18B) | $0.03B | $0.09B | $0.23B |
| Income Tax Expense | $0.04B | ($0.03B) | $0.02B | ($0.02B) | $0.09B |
| Net Income | $0.16B | ($0.15B) | $0.01B | $0.10B | $0.15B |
| Net Margin %(computed) | 10.79% | -8.46% | 0.44% | 4.71% | 5.46% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.25 | $-2.95 | $0.17 | $2.10 | $2.93 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| EBITDA | $0.14B | ($0.08B) | $0.20B | $0.17B | $0.37B |
| EBITDA Margin %(computed) | 9.64% | -4.55% | 10.31% | 7.86% | 13.67% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Nu Skin Enterprises, Inc. data
About Nu Skin Enterprises, Inc. (NUS) Income Statement
Nu Skin Enterprises, Inc. (NUS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NUS reported revenue of $1.49B, gross profit of $1.03B (gross margin 69.45%), and net income of $0.16B — a net profit margin of 10.79%.
Frequently asked questions
NUS · 4 questionsNu Skin Enterprises, Inc. (NUS) reported revenue of $1.49B for 2025, down 14.3% year-over-year.
NUS revenueNUS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08